Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-1992 | 06-1992 | 03-1992 | 12-1991 | 03-1991 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | N/A | N/A | 955 | 955 |
| Marketable Securities | N/A | N/A | N/A | 470 | 470 |
| Receivables | N/A | N/A | N/A | 5,452 | 5,452 |
| Inventories | N/A | N/A | N/A | 4,714 | 4,714 |
| Other current assets | 0 | 0 | 0 | 869 | 869 |
| TOTAL | $N/A | $N/A | $N/A | $12,459 | $12,459 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 0 | 1,497 | 1,497 |
| TOTAL | $N/A | $N/A | $N/A | $1,497 | $1,497 |
| Total Assets | $N/A | $N/A | $N/A | $23,905 | $23,905 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 463 | 463 |
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 4,549 | 4,549 |
| TOTAL | $N/A | $N/A | $N/A | $5,201 | $5,201 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 2,250 | 2,250 |
| TOTAL | $N/A | $N/A | $N/A | $2,736 | $2,736 |
| Total Liabilities | $N/A | $N/A | $N/A | $7,937 | $7,937 |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | N/A | 43 | 43 |
| Retained earnings | N/A | N/A | N/A | 4,175 | 4,175 |
| Other shareholders' equity | 0 | 0 | 0 | -162 | -162 |
| TOTAL | $N/A | $N/A | $N/A | $15,968 | $15,968 |
| Total Liabilities And Equity | $0 | $0 | $0 | $23,905 | $23,905 |